JP2016523558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523558A5 JP2016523558A5 JP2016525289A JP2016525289A JP2016523558A5 JP 2016523558 A5 JP2016523558 A5 JP 2016523558A5 JP 2016525289 A JP2016525289 A JP 2016525289A JP 2016525289 A JP2016525289 A JP 2016525289A JP 2016523558 A5 JP2016523558 A5 JP 2016523558A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- cell
- peptide
- cancer
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2013-0082265 | 2013-07-12 | ||
| KR20130082265 | 2013-07-12 | ||
| KR20130165071 | 2013-12-27 | ||
| KR10-2013-0165071 | 2013-12-27 | ||
| PCT/KR2014/006257 WO2015005723A1 (ko) | 2013-07-12 | 2014-07-11 | 세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016523558A JP2016523558A (ja) | 2016-08-12 |
| JP2016523558A5 true JP2016523558A5 (enExample) | 2017-08-17 |
| JP6574175B2 JP6574175B2 (ja) | 2019-09-11 |
Family
ID=52280308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525289A Active JP6574175B2 (ja) | 2013-07-12 | 2014-07-11 | 細胞透過性ペプチド、及びそれを含むコンジュゲート |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9757473B2 (enExample) |
| EP (1) | EP3020724A4 (enExample) |
| JP (1) | JP6574175B2 (enExample) |
| KR (1) | KR102224965B1 (enExample) |
| CN (1) | CN105531284B (enExample) |
| WO (1) | WO2015005723A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104507961B (zh) | 2012-05-11 | 2018-08-14 | 珍白斯凯尔有限公司 | 抗炎性肽及包含其的组合物 |
| US20150125438A1 (en) | 2012-07-20 | 2015-05-07 | Sang Jae Kim | Anti-Inflammatory Peptides and Composition Comprising the Same |
| CN110074997B (zh) | 2012-09-19 | 2022-07-08 | 珍白斯凯尔有限公司 | 细胞穿透肽、包含该肽的缀合物、及包含该缀合物的组合物 |
| CN104981478B (zh) | 2012-09-19 | 2019-02-22 | 珍白斯凯尔有限公司 | 细胞穿透肽、包含该肽的缀合物、及包含该缀合物的组合物 |
| KR102224965B1 (ko) | 2013-07-12 | 2021-03-09 | 주식회사 젬백스앤카엘 | 세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트 |
| KR102911237B1 (ko) | 2015-05-26 | 2026-01-13 | 주식회사 젬백스앤카엘 | 신규 펩티드 및 이를 포함한 조성물 |
| EP4332219B1 (en) * | 2021-05-14 | 2026-02-18 | Remedi Co., Ltd | Cargo molecule tranduction domain rmad1, variant thereof, recombinant cargo molecule, and method for tranducing cargo molecule using same |
| US20240252660A1 (en) * | 2021-06-03 | 2024-08-01 | Remedi Co., Ltd. | Cargo molecule transduction domain rmmr1, variant thereof, recombinant cargo molecule, and method for transducing cargo molecule using same |
| CN120882737A (zh) | 2023-02-23 | 2025-10-31 | 微肽技术有限公司 | 控制植物病原体的抗真菌肽 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0917579A1 (en) * | 1997-07-01 | 1999-05-26 | Cambia Biosystems LLC | Vertebrate telomerase genes and proteins and uses thereof |
| US7030211B1 (en) * | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
| GB0114719D0 (en) * | 2001-06-15 | 2001-08-08 | Glaxo Group Ltd | Compound |
| WO2003038047A2 (en) * | 2001-10-29 | 2003-05-08 | Baylor College Of Medicine | Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen |
| EP1495045B1 (en) * | 2002-03-29 | 2009-09-02 | Creagene, Inc. | Cytoplasmic transduction peptides and uses thereof |
| US7294708B2 (en) * | 2002-05-31 | 2007-11-13 | Beijing Institute Of Biotechnology | Telomerase reverse transcriptase fragments and uses thereof |
| ATE534661T1 (de) * | 2006-10-12 | 2011-12-15 | Angeletti P Ist Richerche Bio | Fusionsprotein aus telomerase und reverser transkriptase, dafür codierende nukleotide und anwendungen davon |
| KR101169030B1 (ko) | 2009-01-21 | 2012-07-26 | 애니젠 주식회사 | 신규한 세포막 투과 도메인 및 이를 포함하는 세포내 전달 시스템 |
| KR101348284B1 (ko) | 2010-09-09 | 2014-01-03 | 주식회사 나이벡 | 인간 유래 세포 투과성 펩타이드와 생리활성 펩타이드 결합체 및 그 용도 |
| CN102321658A (zh) * | 2011-07-20 | 2012-01-18 | 安徽农业大学 | 猪体细胞的重组蛋白诱变方法 |
| KR101293620B1 (ko) * | 2011-08-19 | 2013-08-13 | 국립암센터 | 트랜스-스플라이싱 라이보자임 및 암치료 유전자를 포함하는 재조합 아데노바이러스 및 이의 용도 |
| KR20130082265A (ko) | 2012-01-11 | 2013-07-19 | 스키너스 주식회사 | 조적벽체 내진보강 구조 |
| KR101444199B1 (ko) * | 2012-02-20 | 2014-09-30 | 대한민국 | 세포막 투과용 단백질 및 그 용도 |
| US20150125438A1 (en) * | 2012-07-20 | 2015-05-07 | Sang Jae Kim | Anti-Inflammatory Peptides and Composition Comprising the Same |
| WO2014046481A1 (ko) * | 2012-09-19 | 2014-03-27 | 주식회사 카엘젬백스 | 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물 |
| KR102224965B1 (ko) | 2013-07-12 | 2021-03-09 | 주식회사 젬백스앤카엘 | 세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트 |
-
2014
- 2014-07-11 KR KR1020167000554A patent/KR102224965B1/ko active Active
- 2014-07-11 WO PCT/KR2014/006257 patent/WO2015005723A1/ko not_active Ceased
- 2014-07-11 CN CN201480050327.8A patent/CN105531284B/zh active Active
- 2014-07-11 US US14/903,827 patent/US9757473B2/en active Active
- 2014-07-11 EP EP14822442.1A patent/EP3020724A4/en not_active Withdrawn
- 2014-07-11 JP JP2016525289A patent/JP6574175B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016523558A5 (enExample) | ||
| Natarajan et al. | Sustained-release from nanocarriers: a review | |
| US12370258B2 (en) | PD-1 and CTLA-4 dual inhibitor peptides | |
| JP2015530358A5 (enExample) | ||
| JP2016527286A5 (enExample) | ||
| CR20200557A (es) | PÉPTIDOS Y COMBINACIÓN DE PÉPTIDOS PARA EL USO EN LA INMUNOTERAPIA CONTRA EL CÁNCER DE MAMA Y OTROS TIPOS DE CÁNCER (Divisional 2018-0135) | |
| EA201891994A1 (ru) | Лечение рака матки | |
| EA201992664A2 (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака яичника и других видов рака | |
| EA202191027A3 (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии нескольких видов опухолей | |
| EP3760225A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| WO2016202963A3 (en) | Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers | |
| SG10201807588TA (en) | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers | |
| HK1259376A1 (zh) | 用於cll和其他癌症免疫治疗的新型肽和肽组合物 | |
| WO2017021527A3 (en) | Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | |
| WO2017005733A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | |
| TW201629096A (zh) | <b>用於肝細胞癌(HCC)和其他癌症免疫治療的新型肽和肽組合</b><b>物</b> | |
| WO2012094653A4 (en) | Compositions and methods for macromolecular drug delivery | |
| MX2018011388A (es) | Peptidos novedosos, combinacion de peptidos y soportes para usarse en el tratamiento inmunoterapeutico de varios tipos de cancer. | |
| JP2016530233A5 (enExample) | ||
| HRP20230878T1 (hr) | Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raznih karcinoma (seq id 25 - mrax5-003) | |
| Waeckerle-Men et al. | Photochemical targeting of antigens to the cytosol for stimulation of MHC class-I-restricted T-cell responses | |
| CR20200059A (es) | Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de pulmón, incluyendo el nsclc, el sclc y otros cánceres | |
| Li et al. | DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy | |
| Mallick et al. | Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer | |
| UA124331C2 (uk) | Пептид, здатний зв'язуватися з молекулою головного комплексу гістосумісності (mhc) людини i класу |